1. Home
  2. NSPR vs UCL Comparison

NSPR vs UCL Comparison

Compare NSPR & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

HOLD

Logo uCloudlink Group Inc.

UCL

uCloudlink Group Inc.

N/A

Current Price

$0.91

Market Cap

38.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
UCL
Founded
2005
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
38.1M
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
NSPR
UCL
Price
$0.72
$0.91
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
85.7K
7.1K
Earning Date
05-04-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
$11.60
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
$13.72
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$0.88
52 Week High
$2.93
$4.19

Technical Indicators

Market Signals
Indicator
NSPR
UCL
Relative Strength Index (RSI) 39.07 44.05
Support Level $0.69 $0.88
Resistance Level $1.04 $0.97
Average True Range (ATR) 0.03 0.04
MACD 0.01 0.00
Stochastic Oscillator 71.29 36.71

Price Performance

Historical Comparison
NSPR
UCL

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.

Share on Social Networks: